| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to the field of biotechnology. Methods include the identification of patients with multiple sclerosis, which have a higher risk of developing a secondary autoimmune disease after the depletion of lymphocytes, caused by, for instance, a course of treatment with an anti-CD52 antibody. Methods of selecting a scheme of treatment for the patients with MS and reagents, suitable for application in the said methods, are also claimed. The claimed group of inventions can be used in medicine.EFFECT: claimed are the methods of diagnosing the patients with multiple sclerosis (MS).27 cl, 13 dwg, 8 ex |
